Value Ceation and Sharing Among Universities, Biotechnology and Pharma

Nature Biotechnology, Vol. 21, No. 6, pp. 618-624, June 2003

7 Pages Posted: 24 May 2006

See all articles by Mark Edwards

Mark Edwards

Recombinant Capital

Fiona Murray

Massachusetts Institute of Technology (MIT) - Entrepreneurship Center

Robert Yu

Recombinant Capital

Abstract

An analysis of deal structures in biotechnology from the past 25 years reveals that universities often neglect important economic aspects in their licensing agreements.

Keywords: biotechnology, licensing

JEL Classification: L14, L31, O34

Suggested Citation

Edwards, Mark and Murray, Fiona E. and Yu, Robert, Value Ceation and Sharing Among Universities, Biotechnology and Pharma. Nature Biotechnology, Vol. 21, No. 6, pp. 618-624, June 2003. Available at SSRN: https://ssrn.com/abstract=904260

Mark Edwards (Contact Author)

Recombinant Capital ( email )

2033 N. Main St.
Suite 1050
Walnut Creek, CA 94596
United States

Fiona E. Murray

Massachusetts Institute of Technology (MIT) - Entrepreneurship Center ( email )

United States

Robert Yu

Recombinant Capital ( email )

2033 N. Main St.
Suite 1050
Walnut Creek, CA 94596
United States
925-952-3870 (Phone)

HOME PAGE: http://www.recap.com

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
200
Abstract Views
1,058
rank
163,126
PlumX Metrics